Relay Therapeutics, Inc. (RLAY)

Healthcare · Biotechnology · NASDAQ

Relay Therapeutics, Inc. (RLAY) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $4.24B and a free-cash-flow yield of -7.1%. Over the most recent reported fiscal year, revenue grew 53.4%.

Market cap	$4.24B
Trailing P/E	—
FCF yield	-7.1%
Revenue growth (YoY)	+53.4%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live RLAY data on Nama Insights →

Recent Congressional trades

Relay Therapeutics, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Daniel Goldman	House	Sell	$1,001 - $15,000	Aug 13, 2023